FT Pharmaceutical Select 41 RE
Name
As of 08/31/2021Price
Aum/Mkt Cap
YIELD
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
Exp Ratio
Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.
Watchlist
Vitals
YTD Return
10.6%
1 yr return
10.2%
3 Yr Avg Return
N/A
5 Yr Avg Return
N/A
Net Assets
$N/A
Holdings in Top 10
52.8%
52 WEEK LOW AND HIGH
$10.8
$8.90
$10.93
Expenses
OPERATING FEES
Expense Ratio 0.22%
SALES FEES
Front Load 0.00%
Deferred Load 2.25%
TRADING FEES
Turnover N/A
Redemption Fee N/A
Min Investment
Standard (Taxable)
$1,000
IRA
$500
Fund Classification
Fund Type
Unknown
Name
As of 08/31/2021Price
Aum/Mkt Cap
YIELD
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
Exp Ratio
Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.
Watchlist
FTTAFX - Profile
Distributions
- YTD Total Return 10.6%
- 3 Yr Annualized Total Return N/A
- 5 Yr Annualized Total Return N/A
- Capital Gain Distribution Frequency N/A
- Net Income Ratio N/A
- Dividend Yield 0.0%
- Dividend Distribution Frequency Monthly
Fund Details
-
Legal NamePharmaceutical Select Portfolio Series 41
-
Fund Family NameFirst Trust Portfolios L.P.
-
Inception DateJul 13, 2020
-
Shares OutstandingN/A
-
Share ClassN/A
-
CurrencyUSD
-
Domiciled CountryUnited States
Fund Description
FTTAFX - Performance
Return Ranking - Trailing
Period | FTTAFX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | 10.6% | -35.0% | 25.3% | 4.15% |
1 Yr | 10.2% | -60.2% | 26.1% | 1.71% |
3 Yr | N/A* | -10.0% | 19.7% | N/A |
5 Yr | N/A* | -6.4% | 16.9% | N/A |
10 Yr | N/A* | 6.4% | 18.5% | N/A |
* Annualized
Return Ranking - Calendar
Period | FTTAFX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2023 | N/A | -79.9% | 24.2% | N/A |
2022 | N/A | -13.6% | 178.2% | N/A |
2021 | N/A | 3.8% | 63.8% | N/A |
2020 | N/A | -49.7% | 21.5% | N/A |
2019 | N/A | -59.8% | 54.4% | N/A |
Total Return Ranking - Trailing
Period | FTTAFX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | 10.6% | -46.5% | 25.3% | 4.15% |
1 Yr | 7.2% | -60.2% | 28.3% | 11.28% |
3 Yr | N/A* | -13.2% | 20.0% | N/A |
5 Yr | N/A* | -6.4% | 16.9% | N/A |
10 Yr | N/A* | 6.4% | 18.5% | N/A |
* Annualized
Total Return Ranking - Calendar
Period | FTTAFX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2023 | N/A | -79.9% | 24.2% | N/A |
2022 | N/A | -13.6% | 178.2% | N/A |
2021 | N/A | 3.8% | 63.8% | N/A |
2020 | N/A | -49.7% | 22.2% | N/A |
2019 | N/A | -59.8% | 54.4% | N/A |
NAV & Total Return History
FTTAFX - Holdings
Concentration Analysis
FTTAFX | Category Low | Category High | FTTAFX % Rank | |
---|---|---|---|---|
Net Assets | N/A | 732 K | 46.2 B | N/A |
Number of Holdings | 26 | 21 | 473 | 94.39% |
Net Assets in Top 10 | 5.28 M | 2.18 K | 21.6 B | 76.64% |
Weighting of Top 10 | 52.84% | 12.3% | 80.8% | 24.30% |
Top 10 Holdings
- AstraZeneca PLC ADR 8.06%
- Horizon Therapeutics PLC 6.47%
- Horizon Therapeutics PLC 6.47%
- Horizon Therapeutics PLC 6.47%
- Horizon Therapeutics PLC 6.47%
- Horizon Therapeutics PLC 6.47%
- Horizon Therapeutics PLC 6.47%
- Horizon Therapeutics PLC 6.47%
- Horizon Therapeutics PLC 6.47%
- Horizon Therapeutics PLC 6.47%
Asset Allocation
Weighting | Return Low | Return High | FTTAFX % Rank | |
---|---|---|---|---|
Stocks | 100.00% | 85.37% | 106.13% | 13.08% |
Preferred Stocks | 0.00% | 0.00% | 7.86% | 41.59% |
Other | 0.00% | -22.99% | 3.38% | 48.13% |
Convertible Bonds | 0.00% | 0.00% | 0.37% | 41.59% |
Cash | 0.00% | -0.10% | 9.01% | 85.05% |
Bonds | 0.00% | 0.00% | 12.39% | 39.72% |
Stock Sector Breakdown
Weighting | Return Low | Return High | FTTAFX % Rank | |
---|---|---|---|---|
Healthcare | 100.00% | 59.26% | 100.00% | 21.03% |
Utilities | 0.00% | 0.00% | 0.00% | 37.85% |
Technology | 0.00% | 0.00% | 22.69% | 42.99% |
Real Estate | 0.00% | 0.00% | 7.13% | 41.59% |
Industrials | 0.00% | 0.00% | 7.02% | 43.46% |
Financial Services | 0.00% | 0.00% | 1.85% | 51.40% |
Energy | 0.00% | 0.00% | 0.00% | 37.85% |
Communication Services | 0.00% | 0.00% | 9.11% | 41.12% |
Consumer Defense | 0.00% | 0.00% | 25.73% | 46.26% |
Consumer Cyclical | 0.00% | 0.00% | 14.20% | 41.12% |
Basic Materials | 0.00% | 0.00% | 14.83% | 57.48% |
Stock Geographic Breakdown
Weighting | Return Low | Return High | FTTAFX % Rank | |
---|---|---|---|---|
US | 60.00% | 53.67% | 104.41% | 99.07% |
Non US | 40.00% | 0.00% | 45.40% | 1.40% |
FTTAFX - Expenses
Operational Fees
FTTAFX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Expense Ratio | 0.22% | 0.08% | 3.13% | 91.71% |
Management Fee | N/A | 0.00% | 1.25% | N/A |
12b-1 Fee | N/A | 0.00% | 1.00% | N/A |
Administrative Fee | N/A | 0.03% | 0.25% | N/A |
Sales Fees
FTTAFX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Front Load | 0.00% | 0.00% | 5.75% | 64.81% |
Deferred Load | 2.25% | 1.00% | 5.00% | 21.57% |
Trading Fees
FTTAFX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Max Redemption Fee | N/A | 1.00% | 2.00% | N/A |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
FTTAFX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Turnover | N/A | 0.00% | 238.00% | N/A |
FTTAFX - Distributions
Dividend Yield Analysis
FTTAFX | Category Low | Category High | FTTAFX % Rank | |
---|---|---|---|---|
Dividend Yield | 0.00% | 0.00% | 3.95% | 1.83% |
Dividend Distribution Analysis
FTTAFX | Category Low | Category High | Category Mod | |
---|---|---|---|---|
Dividend Distribution Frequency | Monthly | Annually | Monthly | Annually |
Net Income Ratio Analysis
FTTAFX | Category Low | Category High | FTTAFX % Rank | |
---|---|---|---|---|
Net Income Ratio | N/A | -2.54% | 1.92% | N/A |
Capital Gain Distribution Analysis
FTTAFX | Category Low | Category High | Capital Mode | |
---|---|---|---|---|
Capital Gain Distribution Frequency | Annually | Semi-Annually | Annually |